25.95
price down icon0.54%   -0.14
after-market Handel nachbörslich: 25.90 -0.05 -0.19%
loading

Liquidia Corp Aktie (LQDA) Neueste Nachrichten

pulisher
08:57 AM

Jefferies initiates Liquidia stock with Buy rating, $43 price target - Investing.com

08:57 AM
pulisher
08:32 AM

Jefferies initiates Liquidia stock with Buy rating, $43 price target By Investing.com - Investing.com UK

08:32 AM
pulisher
Aug 14, 2025

Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.

Aug 14, 2025
pulisher
Aug 13, 2025

Liquidia Technologies stock hits 52-week high at 25.19 USD - Investing.com

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia's Yutrepia Prescriptions Soar, Shares Rise 13.68% - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia (LQDA) Climbs 13.68% as Yutrepia Prescriptions Surge - Insider Monkey

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia (LQDA) Rating Maintained as Strong Buy by Raymond James - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Wells Fargo Raises Liquidia (LQDA) Price Target to $31 | LQDA St - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia Corporation (NASDAQ:LQDA) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 13, 2025
pulisher
Aug 13, 2025

Wells Fargo Raises Liquidia PT to $31 from $25, Maintains Overweight Rating - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia stock price target raised to $31 by Wells Fargo on strong launch - Investing.com

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia stock price target raised to $49 from $40 at BTIG - Investing.com

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia: Needham Raises PT to $36 from $32, Maintains Buy Rating - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YUTREPIA Launch and Financial Position - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YU - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Decoding Liquidia Corp (LQDA): A Strategic SWOT Insight - GuruFocus

Aug 13, 2025
pulisher
Aug 12, 2025

10 Stocks on Euphoria. Are You Holding Any? - Insider Monkey

Aug 12, 2025
pulisher
Aug 12, 2025

United Therapeutics Shares Rise 0.32% Amid Patent Dispute with Liquidia Trading Volume Ranked 420th in Market Activity - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Corporation shares rise 15.19% intraday after reporting positive interim data from ASCENT trial. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia (LQDA): A High-Growth Biotech Play with Explosive Revenue Momentum and a Path to Profitability - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia's Q2 2025 Earnings Call: Unpacking Key Contradictions on YUTREPIA's Market Access and Data Presentation - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Corporation Q2 2025 Earnings Call Transcript Analysis: Key Takeaways and Insights - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Earnings call transcript: Liquidia Q2 2025 sees revenue surge, stock jumps - Investing.com

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Q2 2025 slides: Yutrepia launch drives 141% revenue growth amid widening losses - Investing.com

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Corporation shares surge 13.44% in premarket after strong Q2 earnings and positive drug trial results. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Stock Soars 10.61% on Q2 Earnings - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Technologies earnings missed by $0.07, revenue topped estimates - Investing.com

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Corp SEC 10-Q Report - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update - TradingView

Aug 12, 2025
pulisher
Aug 11, 2025

Earnings To Watch: Liquidia Corp (LQDA) Reports Q2 2025 Result - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Liquidia: Uncertainty Has Always Been A Buying Opportunity (LQDA) - Seeking Alpha

Aug 11, 2025
pulisher
Aug 10, 2025

Will Liquidia Corporation Sustain Its Chart BreakoutReversal Alert Based on RSI Indicator Confirmed - beatles.ru

Aug 10, 2025
pulisher
Aug 08, 2025

Liquidia Corp expected to post a loss of 43 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Liquidia Corporation's (NASDAQ:LQDA) Profit Outlook - Yahoo Finance

Aug 08, 2025
pulisher
Aug 07, 2025

Liquidia Technologies Experiences Promising Start with Yutrepia's Strong Launch - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

Liquidia Technologies stock hits 52-week high at 20.33 USD - Investing.com

Aug 06, 2025
pulisher
Aug 06, 2025

Liquidia Technologies stock hits 52-week high at 20.33 USD By Investing.com - Investing.com UK

Aug 06, 2025
pulisher
Aug 05, 2025

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12 - Quiver Quantitative

Aug 05, 2025
pulisher
Aug 05, 2025

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times

Aug 05, 2025
pulisher
Aug 03, 2025

How does Liquidia Corporation generate profit in a changing economyConsistently outstanding ROI - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Liquidia Corporation stockTremendous growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-03 22:16:43 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Liquidia Corporation stock price move sharplyUnlock daily market insights for better trades - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Why is Liquidia Corporation stock attracting strong analyst attentionMarket-leading profit generation - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Chart Analysts Warn of Resistance Near Liquidia Corporation PriceEarly Entry Picks Before News Breakout Reviewed - metal.it

Aug 02, 2025
pulisher
Aug 01, 2025

BTIG Lowers Liquidia (LQDA) PT to $40, Potential for Yutrepia Launch Remains a Focus - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

Liquidia Corporation shares rise 1.75% after-hours following United Therapeutics' $1 billion accelerated share repurchase program. - AInvest

Aug 01, 2025
pulisher
Jul 31, 2025

Will Liquidia Corporation bounce back from current supportWeekly Return Plan for Conservative Traders - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Is Liquidia Corporation stock poised for growthFree Swing Trading Plan With Smart Signals - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Quantitative breakdown of Liquidia Corporation recent moveFree Trade Scanner With Buy Zone Alerts - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

How Liquidia Corporation stock performs during market volatilityHigh Confidence Strategy with Trend Alignment - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Liquidia's Stock Jumps, But Analyst Skepticism Remains - Finimize

Jul 30, 2025
pulisher
Jul 30, 2025

Drawdown in Liquidia Corporation May Be Nearing EndSmart Investment Tips Gaining Popularity Among Analysts - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Liquidia Corporation Recovery Gathers Momentum on Chart SignalsAlpha Driven Watchlist With Alerts Published - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Sector ETF Data Correlates with Strength in Liquidia CorporationOptimized Watchlist With Daily Adjustments Launched - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Bleecker Street Research short United Therapeutics, long Liquidia - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

RSI + MACD Show Convergence for Liquidia CorporationMarket Entry and Exit Point Tips From Traders - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Fibonacci Levels Suggest Recovery for Liquidia CorporationDaily Momentum Screener With Alerts Launched - metal.it

Jul 29, 2025
$36.34
price down icon 0.44%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):